Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Excelvision is a leading European Contract Development and Manufacturing Organization (CDMO) specializing in the production of ophthalmic pharmaceutical products. Based in Annonay, France, the company provides a comprehensive range of services including the formulation, filling, and packaging of sterile eye drops, ointments, and gels. Since its acquisition by the Fareva Group in 2003, Excelvision has served as a key hub for ophthalmic manufacturing, utilizing advanced technologies such as Blow-Fill-Seal (BFS) and preservative-free multi-dose systems. The company supports global pharmaceutical partners from clinical trial supply through to large-scale commercial distribution. Its facilities are compliant with major international regulatory standards, including the FDA and EMA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Excelvision.